These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 7401801)

  • 1. [The hybrid-DNA technic: the status in Sweden today].
    Kempe C
    Lakartidningen; 1980 Jun; 77(26-27):2448-52. PubMed ID: 7401801
    [No Abstract]   [Full Text] [Related]  

  • 2. [Genetic technic of interest to industry. Rapid development can be expected].
    Nord Med; 1977 Feb; 92(2):60-3. PubMed ID: 320555
    [No Abstract]   [Full Text] [Related]  

  • 3. [The hybrid-DNA technic meets the expectations].
    Philipson L
    Lakartidningen; 1980 Feb; 77(9):757-8. PubMed ID: 7374294
    [No Abstract]   [Full Text] [Related]  

  • 4. [Preparation of drugs and vaccines is revolutionized by the hybrid DNA technic].
    Aberg B
    Lakartidningen; 1983 Dec; 80(52):5081-2. PubMed ID: 6656493
    [No Abstract]   [Full Text] [Related]  

  • 5. [Pharmacy in Norway].
    Karlsen J
    Pharm Weekbl; 1967 Aug; 102(31):771-4. PubMed ID: 5591081
    [No Abstract]   [Full Text] [Related]  

  • 6. Drug sampling: legislation proposed; industry receptive to ending practice.
    Gatty B
    Hosp Formul; 1994 Jun; 29(6):478, 477. PubMed ID: 10134577
    [No Abstract]   [Full Text] [Related]  

  • 7. [More stringent requirements in connection with the choice of drugs. Members of the drug committees in Stockholm deliver an annual declaration of challengeability].
    Sjöqvist F
    Lakartidningen; 2001 Feb; 98(6):541-3. PubMed ID: 11475240
    [No Abstract]   [Full Text] [Related]  

  • 8. [Proposed new law on pharmacy].
    Ugeskr Laeger; 1953 Nov; 115(47):1745-6. PubMed ID: 13136545
    [No Abstract]   [Full Text] [Related]  

  • 9. Enterprise liability for bad outcomes from drug therapy: the doctor, the hospital, the pharmacy, and the drug firm.
    Furrow BR
    Spec Law Dig Health Care Law; 1998 Apr; (229):9-69. PubMed ID: 10178162
    [No Abstract]   [Full Text] [Related]  

  • 10. [Towards a new drug management].
    Hoffmann M; Ahlner J
    Lakartidningen; 1995 Oct; 92(41):3804, 3807. PubMed ID: 7564634
    [No Abstract]   [Full Text] [Related]  

  • 11. NMR studies of fully modified locked nucleic acid (LNA) hybrids: solution structure of an LNA:RNA hybrid and characterization of an LNA:DNA hybrid.
    Nielsen KE; Rasmussen J; Kumar R; Wengel J; Jacobsen JP; Petersen M
    Bioconjug Chem; 2004; 15(3):449-57. PubMed ID: 15149171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Considerations for developing an antiarrhythmic agent: a perspective from the pharmaceutical industry.
    Antonaccio MJ
    Can J Cardiol; 1994 Apr; 10(3):325-6. PubMed ID: 8162528
    [No Abstract]   [Full Text] [Related]  

  • 13. [Medicinal plants. New law in Sweden].
    Nordbø K
    Tidsskr Nor Laegeforen; 1979 Apr; 99(12):601. PubMed ID: 442038
    [No Abstract]   [Full Text] [Related]  

  • 14. The brand name versus generic controversy: Is there a segment of the pharmaceutical industry that produces drugs of higher quality?
    Marsh DA; Hoar ME
    Contemp Pharm Pract; 1982; 5(2):130-5. PubMed ID: 10317245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Limited right to change preparations].
    Svensson C
    Lakartidningen; 1993 Feb; 90(5):350. PubMed ID: 8433622
    [No Abstract]   [Full Text] [Related]  

  • 16. [Special licenses concerning patents for the production of pharmaceuticals and the method of transferring patents].
    MARTELLIERE E
    Prod Pharm; 1955 Jan; 10(1):50-2. PubMed ID: 14371762
    [No Abstract]   [Full Text] [Related]  

  • 17. Pharmaceutical care in community pharmacies: practice and research in Sweden.
    Westerlund LT; Björk HT
    Ann Pharmacother; 2006 Jun; 40(6):1162-9. PubMed ID: 16735653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. No room for compromise. Bill C-22.
    McGillivray D
    CPJ; 1988 Feb; 121(2):88-9. PubMed ID: 10285967
    [No Abstract]   [Full Text] [Related]  

  • 19. [Reorganization of drug provisions in Sweden].
    Félix-Faure LG
    Pharm Weekbl; 1970 Jun; 105(24):700-2. PubMed ID: 5449292
    [No Abstract]   [Full Text] [Related]  

  • 20. Sainsbury Report.
    Br Med J; 1967 Oct; 4(5570):1-2. PubMed ID: 6047821
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.